Depreciation in USD of ABVC BIOPHARMA, INC. from Q1 2018 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
ABVC BIOPHARMA, INC. quarterly/annual Depreciation history and change rate from Q1 2018 to Q3 2025.
  • ABVC BIOPHARMA, INC. Depreciation for the quarter ending 30 Sep 2025 was $5.82K, a 17% decline year-over-year.
  • ABVC BIOPHARMA, INC. Depreciation for the twelve months ending 30 Sep 2025 was $30K, a 2.65% increase year-over-year.
  • ABVC BIOPHARMA, INC. annual Depreciation for 2024 was $32K, a 12.2% increase from 2023.
  • ABVC BIOPHARMA, INC. annual Depreciation for 2023 was $28.5K, a 19.9% increase from 2022.
  • ABVC BIOPHARMA, INC. annual Depreciation for 2022 was $23.8K, a 98.4% increase from 2021.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Change (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Change (%)

ABVC BIOPHARMA, INC. Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $30K $5.82K -$1.19K -17% 01 Jul 2025 30 Sep 2025 10-Q 03 Nov 2025
Q2 2025 $31.2K $6.7K -$6.61K -49.7% 01 Apr 2025 30 Jun 2025 10-Q 13 Aug 2025
Q1 2025 $37.8K $7.02K +$5.74K +446% 01 Jan 2025 31 Mar 2025 10-Q 30 Apr 2025
Q4 2024 $32K $10.4K +$2.84K +37.4% 01 Oct 2024 31 Dec 2024 10-K 15 Apr 2025
Q3 2024 $29.2K $7.01K -$446 -5.98% 01 Jul 2024 30 Sep 2024 10-Q 03 Nov 2025
Q2 2024 $29.6K $13.3K +$6.31K +90.2% 01 Apr 2024 30 Jun 2024 10-Q 13 Aug 2025
Q1 2024 $23.3K $1.29K -$5.21K -80.2% 01 Jan 2024 31 Mar 2024 10-Q 30 Apr 2025
Q4 2023 $28.5K $7.58K 01 Oct 2023 31 Dec 2023 10-K 15 Apr 2025
Q3 2023 $7.46K 01 Jul 2023 30 Sep 2023 10-Q 14 Nov 2024
Q2 2023 $7K 01 Apr 2023 30 Jun 2023 10-Q 14 Aug 2024
Q1 2023 $6.49K +$1.08K +20% 01 Jan 2023 31 Mar 2023 10-Q 17 May 2024
Q1 2022 $5.41K +$2.48K +84.8% 01 Jan 2022 31 Mar 2022 10-Q 15 May 2023
Q2 2021 $21.4K $2.94K -$7.48K -71.8% 01 Apr 2021 30 Jun 2021 10-Q 12 Aug 2021
Q1 2021 $28.9K $2.93K -$8.25K -73.8% 01 Jan 2021 31 Mar 2021 10-Q 16 May 2022
Q4 2020 $37.1K $6.81K -$4.38K -39.1% 01 Oct 2020 31 Dec 2020 10-K 31 Mar 2022
Q3 2020 $41.5K $8.73K -$5.53K -38.8% 01 Jul 2020 30 Sep 2020 10-Q 17 Nov 2020
Q2 2020 $47.1K $10.4K -$5.27K -33.6% 01 Apr 2020 30 Jun 2020 10-Q 12 Aug 2021
Q1 2020 $52.3K $11.2K -$2.77K -19.8% 01 Jan 2020 31 Mar 2020 10-Q 10 May 2021
Q4 2019 $55.1K $11.2K +$823 +7.94% 01 Oct 2019 31 Dec 2019 10-K 16 Mar 2021
Q3 2019 $54.3K $14.3K +$3.69K +34.9% 01 Jul 2019 30 Sep 2019 10-Q 17 Nov 2020
Q2 2019 $50.6K $15.7K +$4.44K +39.5% 01 Apr 2019 30 Jun 2019 10-Q 14 Aug 2020
Q1 2019 $46.1K $13.9K +$2.52K +22.1% 01 Jan 2019 31 Mar 2019 10-Q 29 Jun 2020
Q4 2018 $43.6K $10.4K 01 Oct 2018 31 Dec 2018 10-K 15 May 2020
Q3 2018 $10.6K 01 Jul 2018 30 Sep 2018 10-Q 18 Nov 2019
Q2 2018 $11.3K 01 Apr 2018 30 Jun 2018 10-Q 09 Aug 2019
Q1 2018 $11.4K 01 Jan 2018 31 Mar 2018 10-Q 28 May 2019

ABVC BIOPHARMA, INC. Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $32K +$3.49K +12.2% 01 Jan 2024 31 Dec 2024 10-K 15 Apr 2025
2023 $28.5K +$4.73K +19.9% 01 Jan 2023 31 Dec 2023 10-K 15 Apr 2025
2022 $23.8K +$11.8K +98.4% 01 Jan 2022 31 Dec 2022 10-K 13 Mar 2024
2021 $12K -$25.1K -67.7% 01 Jan 2021 31 Dec 2021 10-K 31 Mar 2023
2020 $37.1K -$17.9K -32.6% 01 Jan 2020 31 Dec 2020 10-K 31 Mar 2022
2019 $55.1K +$11.5K +26.3% 01 Jan 2019 31 Dec 2019 10-K 16 Mar 2021
2018 $43.6K 01 Jan 2018 31 Dec 2018 10-K 15 May 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.